Series
IBB Distinguished Lectures

Permanent Link
https://hdl.handle.net/1853/70905
Series Type
Event Series
Description
Associated Organization(s)
Associated Organization(s)

Filters

2010 - 2018 5
5
5
5
Reset filters

Settings
Start date: 2010 × Has files: Yes × Item Type: Publication ×

Publication Search Results

Now showing 1 - 5 of 5
Thumbnail Image
Item

From Academia to Government to Industry: Lessons Learned

2018-10-31 , Zerhouni, Elias

View
No Thumbnail Available
Item

Investigation of Human Diseases at the Intersections of Engineering, Natural Sciences and Medicine

2011-09-20 , Suresh, Subra

Major advances in various branches of engineering and natural sciences, together with transformational developments in information technology, computational modeling and simulation, genetics, genomics, and nanotechnology, have provided unprecedented opportunities to explore human health and diseases at the cellular and molecular levels. Such developments have also facilitated new opportunities to study fundamental mechanistic processes with the goal of developing basic scientific understanding, new diagnostic tools, and novel therapeutics for a range of human diseases and disorders. This presentation will provide an overview of some recent accomplishments and opportunities for future exploration. Specific examples are drawn from the study of infectious diseases, hereditary blood disorders, and cancer.

View
No Thumbnail Available
Item

Primary Stroke Prevention in Children with Sickle Cell Anemia Living in Africa: The False Choice between Patient Oriented Research and Humanitarian Service

2017-09-19 , DeBaun, Michael R.

View
No Thumbnail Available
Item

Controlling Stem Cells

2010-09-21 , McKay, Ronald D.G.

View
No Thumbnail Available
Item

Biomaterials to Program Cells in situ

2012-09-13 , Mooney, David J.

There are hundreds of clinical trials of cell therapy currently underway, but simple cell infusions lead to large-scale cell death, little control over cell fate, and a typically poor clinical outcome. We propose biomaterials to first serve as cell carriers or attractors of host cell populations, and then serve to program the cells in vivo and ultimately disperse the cells to participate in regeneration or immunotherapy.

View